In summary, our findings are consistent with previous MR studies that reported no associations of genetically determined CRP levels with inflammation-related outcomes including coronary heart disease (42), type 2 diabetes (43), and AD (44). This evidence concerns the gene CRP and type 2 diabetes mellitus.